YI FENG MD NPI 1639179229

NPI Information

  • NPI: 1639179229
  • Provider Name: YI FENG, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7650 DANNAHER DR STE 100
    POWELL, TN
    ZIP 37849
  • Phone: (865) 637-9330

Map and Directions

Get Directions

NPI Details

Yi Feng, MD is a hematology and oncology internal medicine in Powell, TN with 44 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Yi Feng, MD NPI is 1639179229. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7650 DANNAHER DR STE 100
POWELL, TN
ZIP 37849-066
Phone: (865) 637-9330
Fax: (865) 512-6748

The NPI 1639179229 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Magnesium level (HCPCS:83735)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Urinalysis, manual test (HCPCS:81002)
  • Protein measurement, serum (HCPCS:84165)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Urine volume measurement (HCPCS:81050)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)

The enumeration date for this NPI number is 7/26/2005 and was last updated on 4/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology36528KENTUCKYNo
2207RH0003XInternal MedicineHematology & OncologyMD0000038385TENNESSEEYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.